Latest other liabilities for ECTE: $0.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Echo Therapeutics (ECTE) currently reports a other liabilities of $0 as of September 2016. In the prior-year period, the figure was $0. Use the charts on this page to explore Echo Therapeutics's other liabilities history and peer comparisons.
Echo Therapeutics's other liabilities changed from $0 to $0 (period ending September 2016). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Echo Therapeutics reported $0 in other liabilities as of September 2016. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current other liabilities of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Echo Therapeutics, and consider following ECTE for alerts when major investors trade the stock.